Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Spinal cord injury
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseSpinal cord injuryHemisection / partialC57BL/6J host mice; donor progenitors from embryonic day 14 EGFP-expressing C57BL/6 embryosFemale (host mice)n = n = 4 per condition for histology at week 4 (N = 16) and n…Intraspinal implantation of tubes into the hemisection defect and intraspinal injection of cells into the tubes or lesion epicentreFive hydrogel tubes implanted per injury; two intraspinal i…Tubes implanted immediately after the hemisection injury; spinal progenitors in…
Model: C5 lateral hemisection spinal cord injury created under 2% isoflurane after laminectomy, with gelfoam coverage; animals assessed to 4 weeks post-injury
At 2 weeks after transplantation (4 weeks after injury) 4.3% of transplanted E14 spinal progenitors survived when injected into tubes compared with 0.7% when injected into the injury alone, with a higher exogenous nestin-positive progenitor density (5.3 +/- 1.4 versus 1.1 +/- 0.3 cells/mm2, p = 0.0…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.